Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$47.98 - $54.4 $324,920 - $368,396
6,772 Added 3.22%
216,959 $11.8 Million
Q4 2023

Feb 13, 2024

SELL
$48.48 - $57.85 $1.3 Million - $1.55 Million
-26,837 Reduced 11.32%
210,187 $10.8 Million
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $20,029 - $22,396
346 Added 0.15%
237,024 $13.8 Million
Q2 2023

Aug 09, 2023

BUY
$63.71 - $70.74 $8,091 - $8,983
127 Added 0.05%
236,678 $15.1 Million
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $553,475 - $627,766
8,423 Added 3.69%
236,551 $16.4 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $2.1 Million - $2.49 Million
30,702 Added 15.55%
228,128 $16.4 Million
Q3 2022

Nov 10, 2022

BUY
$0.13 - $76.84 $6,406 - $3.79 Million
49,277 Added 33.26%
197,426 $14 Million
Q2 2022

Aug 11, 2022

BUY
$72.62 - $79.98 $834,403 - $918,970
11,490 Added 8.41%
148,149 $11.4 Million
Q1 2022

May 12, 2022

SELL
$61.48 - $73.72 $100,273 - $120,237
-1,631 Reduced 1.18%
136,659 $9.98 Million
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $138,043 - $160,926
-2,574 Reduced 1.83%
138,290 $8.62 Million
Q3 2021

Nov 16, 2021

BUY
$59.17 - $69.31 $714,832 - $837,334
12,081 Added 9.38%
140,864 $8.34 Million
Q2 2021

Aug 13, 2021

BUY
$61.91 - $67.42 $3.58 Million - $3.89 Million
57,749 Added 81.3%
128,783 $8.61 Million
Q1 2021

May 17, 2021

SELL
$59.34 - $66.74 $368,442 - $414,388
-6,209 Reduced 8.04%
71,034 $4.48 Million
Q4 2020

Feb 17, 2021

SELL
$57.74 - $65.43 $595,588 - $674,910
-10,315 Reduced 11.78%
77,243 $4.79 Million
Q3 2020

Nov 13, 2020

BUY
$57.43 - $63.64 $56,338 - $62,430
981 Added 1.13%
87,558 $5.28 Million
Q2 2020

Aug 13, 2020

BUY
$54.82 - $64.09 $32,398 - $37,877
591 Added 0.69%
86,577 $5.09 Million
Q1 2020

May 08, 2020

SELL
$46.4 - $67.43 $170,798 - $248,209
-3,681 Reduced 4.11%
85,986 $4.79 Million
Q4 2019

Feb 10, 2020

BUY
$49.21 - $64.19 $170,020 - $221,776
3,455 Added 4.01%
89,667 $5.75 Million
Q3 2019

Nov 06, 2019

BUY
$42.77 - $50.71 $1.1 Million - $1.3 Million
25,627 Added 42.3%
86,212 $4.36 Million
Q2 2019

Aug 12, 2019

BUY
$44.62 - $49.34 $192,222 - $212,556
4,308 Added 7.65%
60,585 $2.76 Million
Q1 2019

May 06, 2019

SELL
$45.12 - $53.8 $320,532 - $382,195
-7,104 Reduced 11.21%
56,277 $2.7 Million
Q4 2018

Feb 15, 2019

SELL
$48.76 - $63.23 $207,034 - $268,474
-4,246 Reduced 6.28%
63,381 $3.29 Million
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $763,277 - $860,917
13,830 Added 25.71%
67,627 $4.2 Million
Q2 2018

Aug 14, 2018

SELL
$50.53 - $62.98 $72,763 - $90,691
-1,440 Reduced 2.61%
53,797 $2.99 Million
Q1 2018

May 09, 2018

SELL
$59.92 - $68.98 $305,951 - $352,211
-5,106 Reduced 8.46%
55,237 $3.5 Million
Q4 2017

Feb 08, 2018

SELL
$59.94 - $65.35 $121,198 - $132,137
-2,022 Reduced 3.24%
60,343 $3.69 Million
Q3 2017

Nov 16, 2017

SELL
$55.23 - $63.74 $188,555 - $217,608
-3,414 Reduced 5.19%
62,365 $3.97 Million
Q2 2017

Aug 14, 2017

BUY
N/A
65,779
65,779 $3.68 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cetera Advisor Networks LLC Portfolio

Follow Cetera Advisor Networks LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisor Networks LLC with notifications on news.